Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPSE | Q9Y251 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7955687 | 1.00 | HPSE (0.42) | HPSECYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL8319213 | 0.94 | CYP1A2 (0.39) | HPSECYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL7957573 | 0.94 | CYP1A2 (0.39) | HPSECYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL7948101 | 0.89 | CYP1A2 (0.53) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL7948106 | 0.89 | CYP1A2 (0.53) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL7962254 | 0.88 | MAPT (0.40) | ALDH1A1MAPT | |
| SCHEMBL7962256 | 0.88 | MAPT (0.40) | ALDH1A1MAPT | |
| SCHEMBL7957578 | 0.87 | MAPT (0.39) | HPSEALDH1A1MAPT | |
| SCHEMBL7955265 | 0.86 | NT5E (0.51) | HPSE | |
| SCHEMBL7955271 | 0.86 | NT5E (0.51) | HPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0779888-B1 | PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM | BOEHRINGER INGELHEIM PHARMA (DE) | 1999-04-28 | — | — | EP | claimed |
| US-5707989-A | ANTITUMOR AGENTS, INHIBITING SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES | DR. KARL THOMAE GMBH (DE) | 1998-01-13 | — | — | US | claimed |
| US-6271342-B1 | SERUM STABILITY; FOR TUMOR THERAPY | BAYER AKTIENGESELLSCHAFT (DE) | 2001-08-07 | — | — | US | disclosed |
| US-5707989-A | ANTITUMOR AGENTS, INHIBITING SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES | DR. KARL THOMAE GMBH (DE) | 1998-01-13 | — | — | US | disclosed |